vimarsana.com


Why Novavax Stock Is Bound for Massive Gains in 2021
InvestorPlace
1/12/2021
© Source: Ascannio/Shutterstock.com
Novavax (NVAX) logo surrounded by medical supplies
Count
Novavax (NASDAQ:
NVAX) investors among the winners of 2020. At least those who got in early. The biotech company has spent the last decade focused on vaccine development, and that meant a payoff in 2020 when the desperate search for a novel coronavirus vaccine began. Novavax was among the companies on the hunt resulting in huge gains for NVAX stock. At its peak last August, NVAX was up 3,875% from the start of the year! Several companies ultimately beat Novavax to market with vaccines, and that had a cooling effect on the company’s shares.

Related Keywords

Mexico ,Australia ,New Zealand ,Novavax Covid ,Ascannio Shutterstock ,Investorplace Novavax ,Drug Administration ,Tinto Stage ,Fast Track ,Operation Warp Speed ,Inks Big Contracts ,மெக்ஸிகோ ,ஆஸ்திரேலியா ,புதியது ஜீலாந்து ,க்குள் நிலை ,வேகமாக டிராக் ,செயல்பாடு போரிடு வேகம் ,மை பெரியது ஒப்பந்தங்கள் ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.